GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FEED · Jun 30, 2026

ENvue Medical, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-26-038778General Corporate
Capex intensity100thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

11.30% · OPTIONAL · VALID

Operating cash generation7thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1125.94% · OPTIONAL · VALID

Revenue growth0thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.revenue

-51.62% · CORE · VALID

Inventory pressure93thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

1079.92% · OPTIONAL · VALID

Gross margin0thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.gross_margin

-111.30% · CORE · VALID

Operating margin0thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.operating_margin

-2290.38% · CORE · VALID

R&D intensity100thOwn-history percentile · N=15
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

213.39% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History16 statesHistory building
Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20247/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20256/8 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 3
Period transition

What moved in the state?

Capex Intensity Increased
Previous
2.60%
Current
11.30%
Delta
8.69%
Cash Generation Decreased
Previous
-660.34%
Current
-1125.94%
Delta
-465.60%
Growth Decreased
Previous
-36.29%
Current
-51.62%
Delta
-15.33%
Inventory Pressure Increased
Previous
347.01%
Current
1079.92%
Delta
732.90%
Margin Decreased
Previous
-8.42%
Current
-111.30%
Delta
-102.87%
Profitability Decreased
Previous
-568.30%
Current
-2290.38%
Delta
-1722.08%
R And D Intensity Increased
Previous
71.67%
Current
213.39%
Delta
141.72%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Compared To · Orthopedic, Prosthetic & Surgical Appliances & Supplies peers →Has State · ENvue Medical, Inc. →Transitioned To · FEED Fundamental State →Transitioned To · FEED CAPEX_INTENSITY_INCREASED →Transitioned To · FEED CASH_GENERATION_DECREASED →Transitioned To · FEED GROWTH_DECREASED →Transitioned To · FEED INVENTORY_PRESSURE_INCREASED →Transitioned To · FEED MARGIN_DECREASED →Transitioned To · FEED PROFITABILITY_DECREASED →Transitioned To · FEED R_AND_D_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.